M. Wagnerová

发表

Tumour Topoisomerase II Alpha Protein Expression and Outcome After Adjuvant Dose-Dense Anthracycline-Based Chemotherapy

E. Tánczos, T. Brodowicz, Gabriella Uhercsák, 2011, Pathology & Oncology Research.

Laparoscopic hysterectomy in obese women: a clinical prospective study.

Z. Holub, A. Jabor, M. Wagnerová, 2001, European journal of obstetrics, gynecology, and reproductive biology.

Does hysterectomy without salpingo-oophorectomy influence the reoperation rate for adnexal pathology? A retrospective study.

Z. Holub, A. Jabor, M. Wagnerová, 2000, Clinical and experimental obstetrics & gynecology.

Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized phase III trial.

M. Inbar, C. Wiltschke, T. Brodowicz, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lack of correlation between serum and salivary concentration levels of immunoglobulin A and lysozyme (muramidase).

M. Wagnerová, V. Wagner, 1989, Journal of hygiene, epidemiology, microbiology, and immunology.

Safety and efficacy of patupilone in patients with advanced ovarian, primary fallopian, or primary peritoneal cancer: a phase I, open-label, dose-escalation study.

W. M. Smit, A. Oza, H. Hirte, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Human exposure to nickel and cobalt: biological monitoring and immunobiochemical response.

V. Bencko, M. Wagnerová, V. Wagner, 1986, Environmental research.

Levels of alpha 1-antitrypsin in children from areas with different air pollution

M. Wagnerová, V. Wagner, J. Kříž, 1977, International archives of occupational and environmental health.

The levels of transferrin (TRF) in children from three localities with different air pollution under the influence of summer and winter seasons

M. Wagnerová, V. Wagner, J. Kříž, 1979, International archives of occupational and environmental health.

Immunoglobulin (IgG, IgA, IgM) values in a few population groups.

E. Schön, M. Wagnerová, V. Wagner, 1975, Journal of hygiene, epidemiology, microbiology, and immunology.

MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome

A. Kohút, L. Mirossay, J. Mojžiš, 2010, The Pharmacogenomics Journal.

Expression of MDR proteins in breast cancer and its correlation with some clinical and pathological parameters.

L. Plank, S. Rybárová, E. Biros, 2006, Neoplasma.

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.

Tudor Ciuleanu, Jacek Jassem, R. Ramlau, 2006, Lung cancer.

Combination of daily 4-h infusion of 5-fluorouracil and cisplatin in the treatment of advanced head and neck squamous-cell carcinoma: A South-East European Oncology Group study

J. Verweij, J. Jassem, Z. Mechl, 2004, Cancer Chemotherapy and Pharmacology.

Immunological profiles in workers of a power plant burning coal rich in arsenic content.

V. Bencko, J. Bátora, M. Wagnerová, 1988, Journal of hygiene, epidemiology, microbiology, and immunology.

Vinorelbine, epirubicin, and methotrexate (VEM) as primary treatment in locally advanced breast cancer.

J. Abrahámová, I. van Praagh, E. Simova, 2001, The oncologist.

A Review of the Effect of Stress on the Activity of the Central Nervous-Pituitary-Thyroid Axis in Animals and Man (Part 1 of 2)

B. Nashold, V. Synek, J. Kuś, 1968 .

Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG)

T. Brodowicz, S. Špánik, C. Zielinski, 2008, Breast Cancer Research and Treatment.

A Phase II Study of Patupilone (EPO906) in Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer

W. M. Smit, A. Oza, H. Hirte, 2012 .

Phase I/II dose-escalation trial of patupilone every 3 weeks in patients with relapsed/refractory ovarian cancer

W. M. Smit, A. Oza, M. Gore, 2005 .

An epidemiologic-immunological inquiry into the incidence of altered immunity in children of school age.

M. Wagnerová, V. Wagner, V. Zavázal, 1991, Journal of hygiene, epidemiology, microbiology, and immunology.

ESMO takes a stand on supportive and palliative care.

M. Maltoni, M. Tonato, S. Tjulandin, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[Hormone replacement therapy in women with surgical treatment of endometriosis and adenomyosis: prospective and follow-up study. Part I].

Z. Holub, J. Voráček, M. Wagnerová, 2000, Ceska gynekologie.

Humoral defending mechanisms in children of smoking parents.

M. Wagnerová, V. Wagner, L. Háková, 1987, Czechoslovak medicine.

Seasonal variations in the level of immunoglobulins and serum proteins of children differing by exposure to air-borne lead.

M. Wagnerová, V. Wagner, V. Zavázal, 1986, Journal of hygiene, epidemiology, microbiology, and immunology.